Related Experiment Video
Updated: Oct 3, 2026

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Rigid gas-permeable contact lenses are a safe and effective means of treating refractive abnormalities in the
M P Shaughnessy1, F J Ellis, A R Jeffery
1Department of Ophthalmology, Case Western Reserve University, University Hospital of Cleveland, Rainbow Babies and Children's Hospital, OH 44106, USA.
Insights
Rigid gas permeable (RGP) contact lenses are safe and effective for children with various eye conditions, with high wear success rates. Proper family education ensures successful daily use of these pediatric contact lenses.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Contact Lens Technology
Background:
- Refractive errors and corneal irregularities in children often require specialized optical correction.
- Rigid gas permeable (RGP) contact lenses offer unique optical and physiological benefits.
- Assessing the long-term outcomes and practicality of RGP lens wear in pediatric patients is crucial.
Purpose of the Study:
- To evaluate the safety, efficacy, and tolerance of rigid gas permeable (RGP) contact lenses in pediatric patients.
- To determine the economic implications associated with RGP contact lens use in children.
- To assess the feasibility of RGP lens wear for various pediatric ocular conditions.
Main Methods:
- Retrospective chart review of 12 pediatric patients fitted with RGP contact lenses.
- Analysis of patient diagnoses including trauma, high myopia, surgical aphakia, corneal scars, and microphthalmia.
- Evaluation of lens wear duration, daily wear success, extended wear, and adverse events.
Main Results:
- 83.3% of pediatric patients successfully continued RGP contact lens wear after a mean follow-up of 17.8 months.
- 80% of patients achieved success with daily insertion and removal routines.
- No adverse events were reported, though an average of 2.18 replacement lenses were needed per patient every 6 months.
Conclusions:
- Rigid gas permeable (RGP) contact lenses are a safe, effective, and well-tolerated option for pediatric refractive abnormalities.
- Successful daily RGP insertion and removal is achievable with adequate family education.
- Advantages include high oxygen transmissibility and correction of irregular astigmatism, with frequent replacement being a consideration.
Purpose:
This study examined the safety, efficacy, and tolerance of rigid gas permeable (RGP) contact lenses in a pediatric population. The study also considered the economic impact of RGP contact lens wear in children.
Methods:
Retrospectively, we reviewed 12 consecutive charts of children with multiple diagnoses of trauma (n = 5), high myopia (n = 1), surgical aphakia (n = 5), corneal scar (n = 4), and microophthalmia (n = 2) who were considered for RGP contact lenses.
Results:
Fifteen eyes of 12 patients were originally fit with RGP contact lenses. Ten of 12 (83.3%) children were still wearing their RGP contact lenses after a mean follow-up of 17.8 months. Two of 12 patients (16.7%) stopped RGP use. Two of 10 (20%) patients wore their RGP contact lenses for extended wear. Eight of 10 (80%) patients were successful in daily insertion and removal of RGP contact lenses. There were no adverse events secondary to contact lens use in any patients. An average of 2.18 (range: 0.97-4.55) replacement lenses were needed per patient per 6 month interval.
Conclusions:
RGP contact lenses are a safe, effective, and tolerable means of treating refractive abnormalities in the pediatric population. With proper education, families can be successful with daily RGP insertion and removal. RGP contact lenses have the advantage of excellent oxygen transmissibility, low bacterial and protein adherence, and the potential to correct irregular astigmatism. Disadvantages include frequent lens replacement.
Related Concept Videos
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems